179 related articles for article (PubMed ID: 6041002)
1. [Treatment of organic diseases of peripheral arteries with nicotinic acid derivatives].
Liszewska D; Lukasik E
Pol Tyg Lek; 1967 May; 22(21):794-6. PubMed ID: 6041002
[No Abstract] [Full Text] [Related]
2. [Experiences with the treatment of peripheral vascular diseases with Xavin].
Brücknerová O
Vnitr Lek; 1973 Apr; 19(4):379-86. PubMed ID: 4699159
[No Abstract] [Full Text] [Related]
3. [Therapeutic properties of xanthine nicotinate in the treatment of obliterating arteriopathies].
Tardito E; Azzolini A; De Cristofaro A; Papacharalambus D
Minerva Cardioangiol; 1972; 20(7):369-89. PubMed ID: 5050745
[No Abstract] [Full Text] [Related]
4. [Clinical considerations and functional data on the use of the association of kallikrein and meso-inositol hexanicotinate in the therapy of obliterating arteriopathy].
Blasi A; Licciardello M
Clin Ter; 1966 Jul; 38(2):121-58. PubMed ID: 5990194
[No Abstract] [Full Text] [Related]
5. [The vasoactivogram in the treatment of peripheral arteriopathies].
Romeo S; Spinella G; Sciacchitanto D
Angiologia; 1975; 27(1):7-25. PubMed ID: 1111377
[No Abstract] [Full Text] [Related]
6. [Hemokinetic and metabolic action of 7-2-(3-pyridyl-methylamino)-ethyl-theophylline nicotinate as a basis of medical treatment of chronic obliterating peripheral arteriopathy].
Cascio F
Minerva Cardioangiol; 1973 Nov; 21(11):715-31. PubMed ID: 4776567
[No Abstract] [Full Text] [Related]
7. [Effect of prostaglandin E1 in chronic obliterative diseases of peripheral arteries].
Zhang GS
Zhonghua Wai Ke Za Zhi; 1988 Sep; 26(9):541-2, 573. PubMed ID: 3243146
[No Abstract] [Full Text] [Related]
8. [Effect of bencyclane in obliterative arterial diseases].
Kusztos D
Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1419+. PubMed ID: 5536658
[No Abstract] [Full Text] [Related]
9. [Use of a new sympatholytic drug in therapy of chronic peripheral obliterating artery diseases].
Vittori C; Taborelli G; Taborelli R
Minerva Cardioangiol; 1965 Sep; 13(9):585-91. PubMed ID: 5851172
[No Abstract] [Full Text] [Related]
10. [Therapeutic acquisitions on chronic obliterating peripheral arterial diseases of the lower limbs].
Guagliano G; Bagliani A; Borri P
Minerva Med; 1976 May; 67(25):1648-55. PubMed ID: 778666
[No Abstract] [Full Text] [Related]
11. [On the treatment of "intermittent claudication" in chronic peripheral obliterating arteriopathies of the lower extremities caused by arteriosclerosis and Buerger's disease].
Seghezzi R; Pedroni G; Borri P
Chir Ital; 1967; 19():Suppl 2:222+. PubMed ID: 5190600
[No Abstract] [Full Text] [Related]
12. [Peripheral arterial disease--in the field of internal medicine].
Seki K
Nihon Rinsho; 1970 Mar; 28 Suppl():854-5. PubMed ID: 5430911
[No Abstract] [Full Text] [Related]
13. [Treatment of peripheral ischemizing arteriopathies with diisopropylammonium dichloroethanoate (Diedì), a drug with action prevalent on respiratory tissue metabolism].
Maggi GC; Tartara A
Minerva Cardioangiol; 1965 Jul; 13(7):382-3. PubMed ID: 5838538
[No Abstract] [Full Text] [Related]
14. Regression of peripheral atherosclerosis during therapy with high doses of nicotinic acid.
Ost CR; Sténson S
Scand J Clin Lab Invest Suppl; 1967; 99():241-5. PubMed ID: 6056927
[No Abstract] [Full Text] [Related]
15. [Clinical evaluation of Provasan].
Wodniecki J; Wolański A
Wiad Lek; 1970 Oct; 23(20):1791-3. PubMed ID: 5482235
[No Abstract] [Full Text] [Related]
16. [Thrombolytic treatment of chronic arterial obstruction].
Mazák J; Bláha M; Vodicková L; Pidrman V
Vnitr Lek; 1974 Jul; 20(6):596-602. PubMed ID: 4844794
[No Abstract] [Full Text] [Related]
17. [Results of treating obliterative diseases of the peripheral arteries with intra-arterial administrations of acetylcholine].
Stepanova-Nikitina GG; Rage KM
Sov Med; 1970; 33(8):45-9. PubMed ID: 5490077
[No Abstract] [Full Text] [Related]
18. The influence of some drugs on platelet aggregation and adhesion.
Bielawiec M; Perzanowski A; Myśliwiec M
Acta Univ Carol Med Monogr; 1972; 53():211-4. PubMed ID: 4670729
[No Abstract] [Full Text] [Related]
19. Prostacyclin in the therapy of peripheral arterial disease.
Szczeklik A; Gryglewski RJ; Nizankowski R; Szczeklik J; Skawiński S; Głuszko P
Adv Prostaglandin Thromboxane Res; 1980; 7():687-9. PubMed ID: 6989195
[No Abstract] [Full Text] [Related]
20. [Considerations on the use of dextran of low molecular weight in the treatment of peripheral arteriopathy].
Serra GC; Verlato R
Acta Anaesthesiol; 1965; 16():Suppl 5:87-95. PubMed ID: 5899665
[No Abstract] [Full Text] [Related]
[Next] [New Search]
